# HPV Vaccine Immunity in High-risk Women

> **NCT04590521** · PHASE4 · COMPLETED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 63 (actual)

## Conditions studied

- HPV Infection

## Interventions

- **BIOLOGICAL:** Gardasil®, Merck

## Key facts

- **NCT ID:** NCT04590521
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-14
- **Primary completion:** 2023-04-19
- **Final completion:** 2023-04-19
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2024-02-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04590521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04590521, "HPV Vaccine Immunity in High-risk Women". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04590521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*